Evidence map›Paper›PMID 33539926›Full record

ArticleThe Journal of biological chemistry

Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment.

David R McKinzey, Shivasankari Gomathinayagam, Wezley C Griffin, Kathleen N Klinzing, Elizabeth P Jeffries, Aleksandar Rajkovic, Michael A Trakselis

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Structural Activation of DNA Unwinding by MCM8/9/HROB.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. MCM8-9 helicase activity protects primordial germ cell development to prevent premature ovarian insufficiency.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. MCM9 compound heterozygosity in an adolescent with premature ovarian insufficiency.Endocrinology, diabetes & metabolism case reports · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Gerontology through the Eyes of 21st Century Toxicology.Chemical research in toxicology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

David R McKinzeyDepartment of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.
Shivasankari GomathinayagamDepartment of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.
Wezley C GriffinDepartment of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.
Kathleen N KlinzingDepartment of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.
Elizabeth P JeffriesDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Aleksandar RajkovicDepartment of Pathology, University of California San Francisco, San Francisco, California, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA; Institute of Human Genetics, University of California San Francisco, San Francisco, California, USA.
Michael A TrakselisDepartment of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA. Electronic address: michael_trakselis@baylor.edu.
Baylor University · USUniversity of California, San Francisco · USUniversity of Pittsburgh · US

Funding

Unravelling a specific role for MCM8/9 in fork remodelingR15GM135791 · NIGMS · BAYLOR UNIVERSITY · PI TRAKSELIS, MICHAEL A · 2019 to 2019
$416k
NIGMS NIH HHS R15 GM135791
6 · The paper itself

Abstract

The MCM8/9 complex is implicated in aiding fork progression and facilitating homologous recombination (HR) in response to several DNA damage agents. MCM9 itself is an outlier within the MCM family containing a long C-terminal extension (CTE) comprising 42% of the total length, but with no known functional components and high predicted disorder. In this report, we identify and characterize two unique motifs within the primarily unstructured CTE that are required for localization of MCM8/9 to sites of mitomycin C (MMC)-induced DNA damage. First, an unconventional "bipartite-like" nuclear localization (NLS) motif consisting of two positively charged amino acid stretches separated by a long intervening sequence is required for the nuclear import of both MCM8 and MCM9. Second, a variant of the BRC motif (BRCv) similar to that found in other HR helicases is necessary for localization to sites of MMC damage. The MCM9-BRCv directly interacts with and recruits RAD51 downstream to MMC-induced damage to aid in DNA repair. Patient lymphocytes devoid of functional MCM9 and discrete MCM9 knockout cells have a significantly impaired ability to form RAD51 foci after MMC treatment. Therefore, the disordered CTE in MCM9 is functionally important in promoting MCM8/9 activity and in recruiting downstream interactors; thus, requiring full-length MCM9 for proper DNA repair.

Indexed as

Antibiotics, AntineoplasticCell Line, TumorDNA DamageHEK293 CellsHumansMinichromosome Maintenance ProteinsMitomycinRad51 RecombinaseAntibiotics, AntineoplasticMCM9 protein, humanMinichromosome Maintenance ProteinsMitomycinRad51 RecombinaseBRC variant motifDNA repairhomologous recombinationMCM9mitomycin CNLSRad51

Identifiers

PMID33539926
PMCPMC7949153
OpenAlexW3127711237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.